S. 3430 — 118th Congress
Federal bill
Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
- Title
- Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
- Official title
- An original bill to amend titles XVIII and XIX of the Social Security Act to expand the mental health care workforce and services, reduce prescription drug costs, and extend certain expiring provisions under Medicare and Medicaid, and for other purposes.
- Type
- Senate bill
- Congress
- 118th Congress
- Chamber of origin
- Senate
- Introduced
- 2023-12-07
- Latest action
- Placed on Senate Legislative Calendar under General Orders. Calendar No. 265.
- Latest action date
- 2023-12-07
Organizations that named this bill in federal lobbying filings
- AMERICAN PSYCHIATRIC ASSOCIATION Federal lobbying client (LDA)
- NATIONAL ALLIANCE ON MENTAL ILLNESS Federal lobbying client (LDA)
- TRUST FOR AMERICA'S HEALTH Federal lobbying client (LDA)
- AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES INC.(FKA AMERICAN PSYCHOLOGICAL ASSN Federal lobbying client (LDA)
- NATIONAL ASSOCIATION OF SOCIAL WORKERS Federal lobbying client (LDA)
- CHRISTUS HEALTH SYSTEM Federal lobbying client (LDA)
- GREATER NEW YORK HOSPITAL ASSOCIATION Federal lobbying client (LDA)
- AMERICAN COLLEGE OF EMERGENCY PHYSICIANS Federal lobbying client (LDA)
- ASSOCIATION OF AMERICAN MEDICAL COLLEGES Federal lobbying client (LDA)
- BLUE CROSS AND BLUE SHIELD ASSOCIATION Federal lobbying client (LDA)
- BLUE CROSS BLUE SHIELD OF MICHIGAN Federal lobbying client (LDA)
- BOSTON MEDICAL CENTER Federal lobbying client (LDA)
- NATIONAL ASSOCIATION OF SOCIAL WORKERS Federal lobbying client (LDA)
- AARP Federal lobbying client (LDA)
- BLUE CROSS AND BLUE SHIELD OF FLORIDA INC Federal lobbying client (LDA)
- GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS Federal lobbying client (LDA)
- GSK (FKA GLAXOSMITHKLINE INC.) Federal lobbying client (LDA)
- NATIONAL COMMUNITY PHARMACISTS ASSOCIATION Federal lobbying client (LDA)
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA Federal lobbying client (LDA)
- PRIME THERAPEUTICS Federal lobbying client (LDA)
- UNIVERSITY OF CALIFORNIA Federal lobbying client (LDA)
Federal lobbying filings naming this bill
U.S. Senate Lobbying Disclosure Act database. A filing names bills, issues and agencies — never the member lobbied — so these rows point only at the client organization, and none of them says any member of Congress was lobbied about this bill. The count is filings in this site's LDA slice, not the
- AMERICAN PSYCHIATRIC ASSOCIATION cited in the filing's issue text 5 filings
- NATIONAL ALLIANCE ON MENTAL ILLNESS cited in the filing's issue text 5 filings
- TRUST FOR AMERICA'S HEALTH cited in the filing's issue text 5 filings
- AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES INC.(FKA AMERICAN PSYCHOLOGICAL ASSN cited in the filing's issue text 4 filings
- NATIONAL ASSOCIATION OF SOCIAL WORKERS cited in the filing's issue text 4 filings
- CHRISTUS HEALTH SYSTEM cited in the filing's issue text 3 filings
- GREATER NEW YORK HOSPITAL ASSOCIATION cited in the filing's issue text 3 filings
- AMERICAN COLLEGE OF EMERGENCY PHYSICIANS cited in the filing's issue text 2 filings
- ASSOCIATION OF AMERICAN MEDICAL COLLEGES cited in the filing's issue text 2 filings
- BLUE CROSS AND BLUE SHIELD ASSOCIATION cited in the filing's issue text 2 filings
- BLUE CROSS BLUE SHIELD OF MICHIGAN cited in the filing's issue text 2 filings
- BOSTON MEDICAL CENTER cited in the filing's issue text 2 filings
- NATIONAL ASSOCIATION OF SOCIAL WORKERS cited in the filing's issue text 2 filings
- AARP cited in the filing's issue text 1 filing
- BLUE CROSS AND BLUE SHIELD OF FLORIDA INC cited in the filing's issue text 1 filing
- GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS cited in the filing's issue text 1 filing
- GSK (FKA GLAXOSMITHKLINE INC.) cited in the filing's issue text 1 filing
- NATIONAL COMMUNITY PHARMACISTS ASSOCIATION cited in the filing's issue text 1 filing
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA cited in the filing's issue text 1 filing
- PRIME THERAPEUTICS cited in the filing's issue text 1 filing